No CRS summary available for this bill.
This section directs the Secretary of Health and Human Services, not later than one year after enactment, to complete a study on fentanyl testing (in addition to testing for substances such as amphetamines, phencyclidine, cocaine, opiates, and marijuana) in hospital emergency departments (as defined in EMTALA, 42 U.S.C. 1395dd(a)) for patients experiencing an overdose—including the frequency of such testing, associated costs, patient benefits and risks, and impacts on patient experience such as confidentiality of personal health information and the patient-physician relationship. Not later than six months after completing the study, the Secretary must issue guidance on (1) whether such departments should routinely test overdose patients for fentanyl, (2) ensuring clinician awareness of substances tested in routine drug screens regardless of fentanyl inclusion, and (3) effects of fentanyl testing on future overdose risk and general health outcomes.